BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8910855)

  • 1. Involvement of a cytochrome P450 system in microsomal debromination of alpha-(bromisovaleryl)urea.
    Oka K; Kitamura S; Tatsumi K
    J Pharm Pharmacol; 1996 Sep; 48(9):930-2. PubMed ID: 8910855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P450.
    Zbaida S; Levine WG
    Biochem Pharmacol; 1990 Dec; 40(11):2415-23. PubMed ID: 2125221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver.
    Walton MI; Wolf CR; Workman P
    Biochem Pharmacol; 1992 Jul; 44(2):251-9. PubMed ID: 1642640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
    Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
    Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
    Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
    Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
    Goeptar AR; te Koppele JM; van Maanen JM; Zoetemelk CE; Vermeulen NP
    Biochem Pharmacol; 1992 Jan; 43(2):343-52. PubMed ID: 1310854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cimetidine with cytochrome P450 and effect on mixed-function oxidase activities of liver microsomes.
    Faux SP; Combes RD
    Hum Exp Toxicol; 1993 Mar; 12(2):147-52. PubMed ID: 8096713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450.
    Nebbia C; Ceppa L; Dacasto M; Carletti M
    J Toxicol Environ Health A; 1999 Mar; 56(6):433-47. PubMed ID: 10096365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the antioxidant capacities of some benzimidazoles in rat tissues.
    Can-Eke B; Puskullu MO; Buyukbingol E; Iscan M
    Chem Biol Interact; 1998 May; 113(1):65-77. PubMed ID: 9630848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
    Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
    Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective N-demethylation of chlorpheniramine by rat-liver microsomes and the involvement of cytochrome P450 isozymes.
    Nomura A; Sakurai E; Hikichi N
    J Pharm Pharmacol; 1997 Mar; 49(3):257-62. PubMed ID: 9231341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel class of cytochrome P450 reductase redox cyclers: cationic manganoporphyrins.
    Day BJ; Kariya C
    Toxicol Sci; 2005 May; 85(1):713-9. PubMed ID: 15703263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnenolone-16alpha-carbonitrile-inducible cytochrome P450 in rat liver.
    Birnbaum LS; Baird MB; Massie HR
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):553-62. PubMed ID: 825936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase.
    Vromans RM; van de Straat R; Groeneveld M; Vermeulen NP
    Xenobiotica; 1990 Sep; 20(9):967-78. PubMed ID: 2122607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytochrome P4501A in biotransformation of the potential anticancer drug oracin.
    Szotáková B; Wsól V; Skálová L; Kvasnicková E
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):428-31. PubMed ID: 10445410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beta-ionone on the expression of cytochrome P450s and NADPH-cytochrome P450 reductase in Sprague Dawley rats.
    Jeong TC; Gu HK; Chun YJ; Yun CH; Han SS; Roh JK
    Chem Biol Interact; 1998 Jul; 114(1-2):97-107. PubMed ID: 9744558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron-transport cytochrome P-450 system is involved in the microsomal metabolism of the carcinogen chromate.
    Garcia JD; Jennette KW
    J Inorg Biochem; 1981 Jul; 14(4):281-95. PubMed ID: 6792322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro induction of cytochrome P450 enzymes in beagle dogs.
    Graham RA; Downey A; Mudra D; Krueger L; Carroll K; Chengelis C; Madan A; Parkinson A
    Drug Metab Dispos; 2002 Nov; 30(11):1206-13. PubMed ID: 12386126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
    Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
    Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.